Back to Search
Start Over
Economic Burden of Chronic Conditions Among Survivors of Cancer in the United States.
- Source :
-
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Jun 20; Vol. 35 (18), pp. 2053-2061. Date of Electronic Publication: 2017 May 04. - Publication Year :
- 2017
-
Abstract
- Purpose The prevalence of cancer survivorship and chronic health conditions is increasing. Limited information exists on the economic burden of chronic conditions among survivors of cancer. This study examines the prevalence and economic effect of chronic conditions among survivors of cancer. Methods Using the 2008 to 2013 Medical Expenditure Panel Survey, we present nationally representative estimates of the prevalence of chronic conditions (heart disease, high blood pressure, stroke, emphysema, high cholesterol, diabetes, arthritis, and asthma) and multiple chronic conditions (MCCs) and the incremental annual health care use, medical expenditures, and lost productivity for survivors of cancer attributed to individual chronic conditions and MCCs. Incremental use, expenditures, and lost productivity were evaluated with multivariable regression. Results Survivors of cancer were more likely to have chronic conditions and MCCs compared with adults without a history of cancer. The presence of chronic conditions among survivors of cancer was associated with substantially higher annual medical expenditures, especially for heart disease ($4,595; 95% CI, $3,262 to $5,927) and stroke ($3,843; 95% CI, $1,983 to $5,704). The presence of four or more chronic conditions was associated with increased annual expenditures of $10,280 (95% CI, $7,435 to $13,125) per survivor of cancer. Annual lost productivity was higher among survivors of cancer with other chronic conditions, especially stroke ($4,325; 95% CI, $2,687 to $5,964), and arthritis ($3,534; 95% CI, $2,475 to $4,593). Having four or more chronic conditions was associated with increased annual lost productivity of $9,099 (95% CI, $7,224 to $10,973) per survivor of cancer. The economic impact of chronic conditions was similar among survivors of cancer and individuals without a history of cancer. Conclusion These results highlight the importance of ensuring access to lifelong personalized screening, surveillance, and chronic disease management to help manage chronic conditions, reduce disruptions in employment, and reduce medical expenditures among survivors of cancer.
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Arthritis economics
Arthritis epidemiology
Asthma economics
Asthma epidemiology
Cardiovascular Diseases epidemiology
Chronic Disease
Diabetes Mellitus economics
Diabetes Mellitus epidemiology
Efficiency
Emphysema economics
Emphysema epidemiology
Female
Heart Diseases economics
Heart Diseases epidemiology
Humans
Hypercholesterolemia economics
Hypercholesterolemia epidemiology
Hypertension economics
Hypertension epidemiology
Male
Middle Aged
Neoplasms economics
Prevalence
Stroke economics
Stroke epidemiology
United States epidemiology
Young Adult
Cardiovascular Diseases economics
Cost of Illness
Health Expenditures statistics & numerical data
Health Services statistics & numerical data
Neoplasms epidemiology
Survivors statistics & numerical data
Subjects
Details
- Language :
- English
- ISSN :
- 1527-7755
- Volume :
- 35
- Issue :
- 18
- Database :
- MEDLINE
- Journal :
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 28471724
- Full Text :
- https://doi.org/10.1200/JCO.2016.71.9716